Purchase Order 75N91024P00209
Award Date 2/1/24
Potential Completion Date 3/31/24
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Genscript USA Inc. has been awarded a $24,705 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide services for creating customized monoclonal antibodies and plasmids in support of the agency's biomedical research efforts. As the prime contractor, Genscript will leverage its expertise in gene synthesis and monoclonal antibody development to deliver the requested biological products and services. This contract...
- This firm fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $15,289.00 contract will run through September 30, 2024 and does not have a set-aside designation. Genscript specializes in gene synthesis, gene editing, custom protein and antibody production, and other molecular biology services that support...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $13,459 purchase order to Genscript USA Inc. to provide custom subcloning and antibody sequencing services in support of the agency's biomedical research efforts. Work will be performed by Genscript in Piscataway, New Jersey over a three-month period concluding in early October 2023. The firm fixed price contract was awarded under an unidentified agency-wide...
- This federal contract award to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey, was issued by the National Cancer Institute, a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $4,217.03 firm fixed-price delivery order is for peptide services and does not have a set-aside designation. Genscript is a major provider of molecular biology products and services to federal agencies, including the NIH, Centers...
- This is a $24,564.70 firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is for antibody fragment humanization services, which involves modifying antibody proteins to make them more suitable for human therapeutic use. The contract does not have a set-aside designation. Genscript has a history of providing specialized molecular biology services,...
- The National Cancer Institute awarded a $17,064.17 firm fixed price contract to Genscript USA Inc. under a Blanket Purchase Agreement (BPA) call for the production of three custom antibodies and associated proteins required for antibody production. The award was made on November 18, 2019, with an ultimate completion date of January 3, 2025. The contract was processed to de-obligate expiring FY20 funding lines in accordance with NIH Office of Administrative Law and Management (OALM) Communication...
- The National Institute of Allergy and Infectious Diseases awarded a $16,974.27 firm fixed price purchase order to Genscript USA Inc. for antibody gene synthesis and production services. The contract was awarded on August 26, 2020, with an ultimate completion date of February 6, 2021, and was performed at Genscript's facility in Piscataway, New Jersey. This award did not utilize any set-aside designation and represents a straightforward procurement of specialized molecular biology services...
- This contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $3,182.40 firm fixed price delivery order is for gene synthesis services. Genscript specializes in providing customized DNA, antibodies, proteins, peptides, and other molecular biology products and services to support biomedical research and public health initiatives...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Genscript USA Inc., a biotechnology company, for the provision of DNA expression constructs. The contract has a potential value of $12,475.22 and a completion date of November 2, 2023. Genscript has provided similar services to federal agencies in the past, supporting biomedical research and public health initiatives...
- This $8,435.16 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services' National Institutes of Health, to Genscript USA Inc., a for-profit biotechnology company located in Piscataway, New Jersey. The contract is for antibody production services, with a completion date of June 15, 2018. Genscript specializes in providing a range of biomedical research and public health products and services to...